RE: Under the radar18 May 2026 22:48
I understand the nature of your hunch chester, though actually there's no logic to it - the SP has repeatedly defied charting analysis over the past weeks - we all likely have batches of shares bought at 7p, 8p, 9p etc, so the profits are already very handsome (small apartment-sized for me) and there will be some growing pressure to cash in these profits, but as yet, strangely, no evidence of that occurring. Could it be that over all the patient years LTH's have developed an awareness that Scancell has multiple leading oncology platforms on its hands? (After all, the usually modest Lindy has more than once called them "the best"!). My own hunch is: hold until at least the second piece of news - it will be clear then whether the SP will settle around broker target, or will head to the stratosphere. If everything works as intended, it's something like a 20 bagger from here.